It has been reported that low expression levels of KLF3 in tumors are caused by DNA methylation.16 More importantly, DNA methylation inhibitors have been applied in clinical practice, suggesting that the expression of KLF3 might be promoted by DNA methylation inhibitors in clinical patients with lung cancer to improve the prognosis. Here, KLF3 is linked to lung cancer.